![](images/null.gif) |
![](images/null.gif) |
![](images/null.gif) |
|
Effects of Inarigivir (SB9200) Therapy on Immune Responses in Patients with Chronic Hepatitis B (CHB)
|
|
|
pdf of slide presentation attached so you can read small details of data in slides below
Download the PDF here
Reported by Jules Levin
EASL 2018 April 11-15 Paris France
Renae Walsh1, Rachel Hammond1, Kathy Jackson1, Ros
Edwards1, Chelsea Macfarlane2, Radhakrishnan P. Iyer2,
Man-Fung Yuen3, Henry LY Chan4, Nezam H. Afdhal2,
Stephen Locarnini1
1 Victorian Infectious Diseases Reference Laboratory,
Melbourne, Australia
2 Spring Bank Pharmaceuticals, Hopkinton, MA, United States
3 University of Hong Kong, Hong Kong, Hong Kong
4 Chinese University of Hong Kong, Hong Kong, Hong Kong
![0427181](../images%20/042718/042718-4/0427181.gif)
![0427182](../images%20/042718/042718-4/0427182.gif)
![0427183](../images%20/042718/042718-4/0427183.gif)
![0427184](../images%20/042718/042718-4/0427184.gif)
![0427185](../images%20/042718/042718-4/0427185.gif)
![0427186](../images%20/042718/042718-4/0427186.gif)
![0427187](../images%20/042718/042718-4/0427187.gif)
![0427188](../images%20/042718/042718-4/0427188.gif)
![0427189](../images%20/042718/042718-4/0427189.gif)
![04271810](../images%20/042718/042718-4/04271810.gif)
![04271811](../images%20/042718/042718-4/04271811.gif)
![04271812](../images%20/042718/042718-4/04271812.gif)
![04271813](../images%20/042718/042718-4/04271813.gif)
![04271814](../images%20/042718/042718-4/04271814.gif)
![04271815](../images%20/042718/042718-4/04271815.gif)
![04271816](../images%20/042718/042718-4/04271816.gif)
![04271817](../images%20/042718/042718-4/04271817.gif)
![04271818](../images%20/042718/042718-4/04271818.gif)
|
|
|
![](images/null.gif) |
![](images/null.gif) |
|
|